|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| (11) | Number of the document | 3242890 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16700136.1 |
| Date of filing the European patent application | 2016-01-08 | |
| (97) | Date of publication of the European application | 2017-11-15 |
| (45) | Date of publication and mention of the grant of the patent | 2019-09-04 |
| (46) | Date of publication of the claims translation | 2019-12-27 |
| (86) | Number | PCT/EP2016/050308 |
| Date | 2016-01-08 |
| (87) | Number | WO 2016/110584 |
| Date | 2016-07-14 |
| (30) | Number | Date | Country code |
| PCT/EP2015/0502 | 2015-01-08 | WO |
| (72) |
SAHIN, Ugur, DE
GIESEKE, Friederike, DE
ALTINTAS, Isil, NL
SATIJN, David, NL
PARREN, Paul, NL
|
| (73) |
Genmab A/S,
Kalvebod Brygge 43, 1560 Copenhagen V,
DK
BioNTech SE, An der Goldgrube 12, 55131 Mainz, DE |
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | TNF receptorių surišantys agonistiniai agentai |
| AGONISTIC TNF RECEPTOR BINDING AGENTS |
| Payment date | Validity (years) | Amount | |
| 2025-12-29 | 11 | 289.00 EUR |
| 2027-01-08 |